Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...
Automation can offer labs a vast range of benefits, from improving productivity and accuracy to enabling researchers to focus on less menial tasks. Despite this potential, many labs are hesitant to ...
insights from industryBernd GleixnerDivision President AutomationBruker Biopsin News Medical speaks to Bernd Gleixner, Division President Automation at Bruker Biospin, about the future of lab ...
Are you working for your data or are your data working for you? Over the last decade or so, labs have made the move from paper lab notebooks to digital laboratory platforms (DLPs). This is a great ...
The lab automation market is expected to surpass $8.36 billion globally in 2025 and reach $14.78 billion by 2034. Pharmaceutical and biotech companies are making huge investments in lab automation ...
Labroots is delighted to host the 8th Annual Event in the Laboratory Automation Virtual Event Series, scheduled on March 20th, 2024! Dive into the cutting edge of laboratory technology at this free ...
Addressing the key questions about the role of actuators in medical testing environments explains why actuator designs are changing to handle mass processing and eliminate ...
Telos Scientific Suggests Putting the Integration of Laboratory Automation on AutoPilot Telos Scientific is the developer of AutoPilot, a technology that can allow scientists who lack programming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results